CRC has an immunosuppressive TME which helps prevent the development of an effective response to ICB therapies. There is certainly Hence an urgent must establish the ways reprogram this suppressive TME in order to enrich immunotherapy efficacy. In the current research, we made use of CRISPR KO screens to find https://carolineh207ydi1.blogitright.com/profile